| High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease PJ Thornalley, R Babaei-Jadidi, H Al Ali, N Rabbani, A Antonysunil, ... Diabetologia 50 (10), 2164-2170, 2007 | 341 | 2007 |
| High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study N Rabbani, SS Alam, S Riaz, JR Larkin, MW Akhtar, T Shafi, ... Diabetologia 52 (2), 208-212, 2009 | 215 | 2009 |
| Recent advances in SALDI-MS techniques and their chemical and bioanalytical applications KP Law, JR Larkin Analytical and bioanalytical chemistry 399 (8), 2597-2622, 2011 | 202 | 2011 |
| Accurate and reliable high-throughput detection of copy number variation in the human genome H Fiegler, R Redon, D Andrews, C Scott, R Andrews, C Carder, R Clark, ... Genome research 16 (12), 1566-1574, 2006 | 175 | 2006 |
| ASPP2 controls epithelial plasticity and inhibits metastasis through β-catenin-dependent regulation of ZEB1 Y Wang, F Bu, C Royer, S Serres, JR Larkin, MS Soto, NR Sibson, ... Nature cell biology 16 (11), 1092-1104, 2014 | 127 | 2014 |
| A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis AM Dickens, JR Larkin, JL Griffin, A Cavey, L Matthews, MR Turner, ... Neurology 83 (17), 1492-1499, 2014 | 76 | 2014 |
| Imaging of translocator protein upregulation is selective for pro‐inflammatory polarized astrocytes and microglia M Pannell, V Economopoulos, TC Wilson, V Kersemans, PG Isenegger, ... Glia 68 (2), 280-297, 2020 | 66 | 2020 |
| Anti-inflammatory microglia/macrophages as a potential therapeutic target in brain metastasis KE Andreou, MS Soto, D Allen, V Economopoulos, A De Bernardi, ... Frontiers in oncology 7, 251, 2017 | 55 | 2017 |
| Glucose-induced down regulation of thiamine transporters in the kidney proximal tubular epithelium produces thiamine insufficiency in diabetes JR Larkin, F Zhang, L Godfrey, G Molostvov, D Zehnder, N Rabbani, ... PLoS One 7 (12), e53175, 2012 | 51 | 2012 |
| Molecular magnetic resonance imaging of angiogenesis in vivo using polyvalent cyclic RGD-iron oxide microparticle conjugates S Melemenidis, A Jefferson, N Ruparelia, AM Akhtar, J Xie, D Allen, ... Theranostics 5 (5), 515, 2015 | 49 | 2015 |
| Activation of the unfolded protein response in high glucose treated endothelial cells is mediated by methylglyoxal Z Irshad, M Xue, A Ashour, JR Larkin, PJ Thornalley, N Rabbani Scientific reports 9 (1), 1-14, 2019 | 48 | 2019 |
| Tumor pH and protein concentration contribute to the signal of amide proton transfer magnetic resonance imaging KJ Ray, MA Simard, JR Larkin, J Coates, P Kinchesh, SC Smart, ... Cancer research 79 (7), 1343-1352, 2019 | 43 | 2019 |
| Covalent assembly of nanoparticles as a peptidase-degradable platform for molecular MRI F Perez-Balderas, SI Van Kasteren, AAA Aljabali, K Wals, S Serres, ... Nature communications 8 (1), 1-10, 2017 | 38 | 2017 |
| The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis E Gray, JR Larkin, TDW Claridge, K Talbot, NR Sibson, MR Turner Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16 (7-8), 456-463, 2015 | 38 | 2015 |
| 13C pyruvate transport across the blood-brain barrier in preclinical hyperpolarised MRI JJ Miller, JT Grist, S Serres, JR Larkin, AZ Lau, K Ray, KR Fisher, ... Scientific reports 8 (1), 1-15, 2018 | 37 | 2018 |
| Determination of an optimally sensitive and specific chemical exchange saturation transfer MRI quantification metric in relevant biological phantoms KJ Ray, JR Larkin, YK Tee, AA Khrapitchev, G Karunanithy, M Barber, ... NMR in Biomedicine 29 (11), 1624-1633, 2016 | 25 | 2016 |
| Quantitative blood flow measurement in rat brain with multiphase arterial spin labelling magnetic resonance imaging JR Larkin, MA Simard, AA Khrapitchev, JA Meakin, TW Okell, M Craig, ... Journal of Cerebral Blood Flow & Metabolism 39 (8), 1557-1569, 2019 | 20 | 2019 |
| High glucose causes a decrease in expression of thiamine transporters in human proximal tubule epithelial cells in vitro JR Larkin, PJ Thornalley Diabetologia 51, S97-S97, 2008 | 17 | 2008 |
| Development of therapeutic anti-JAGGED1 antibodies for cancer therapy M Masiero, D Li, P Whiteman, C Bentley, J Greig, T Hassanali, S Watts, ... Molecular cancer therapeutics 18 (11), 2030-2042, 2019 | 16 | 2019 |
| NMR-based metabolomics separates the distinct stages of disease in a chronic relapsing model of multiple sclerosis AM Dickens, JR Larkin, BG Davis, JL Griffin, TDW Claridge, NR Sibson, ... Journal of Neuroimmune Pharmacology 10 (3), 435-444, 2015 | 13 | 2015 |
Michael A ChappellUniversity of NottinghamVerified email at nottingham.ac.uk
